Calciscon Overview

  • Founded
  • 2013
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Series A
  • (Cancelled)
  • Investors
  • 4

Calciscon General Information


Developer of calcification propensity diagnostics designed to improve the cardiovascular risk management of kidney patients. The company's calcification propensity test measures crystal formation time, Magnesium in serum and Fetuin-A in serum, it also offers a measurement service for testing Calcification Propensity in blood, urine or other sample types, enabling patients to identify patients at elevated risk to develop pathologic calcification.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • Aarbergstrasse 5
  • 2560 Nidau
  • Switzerland
+41 032 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Calciscon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 23-Jul-2020 Cancelled Generating Revenue
7. Seed Round 23-Jul-2020 00000 00.000 Completed Generating Revenue
6. Accelerator/Incubator 01-Sep-2017 00.00 Completed Startup
5. Debt - General 01-Jan-2016 00.00 Completed Startup
4. Seed Round 23-Mar-2015 00.000 00.00 00.00 Completed Startup
3. Grant 18-Jun-2014 00000 00000 Completed Startup
2. Accelerator/Incubator 07-Apr-2014 $147K $147K Completed Startup
1. Grant 03-Dec-2013 $164K Completed Startup
To view Calciscon’s complete valuation and funding history, request access »

Calciscon Executive Team (3)

Name Title Board Seat Contact Info
Vincent Linder Ph.D Chief Executive Officer & Board Member
Andreas Pasch MD Co-Founder, Chief Medical Officer & Chairman
You’re viewing 2 of 3 executive team members. Get the full list »

Calciscon Board Members (5)

Name Representing Role Since
Andreas Pasch MD Calciscon Co-Founder, Chief Medical Officer & Chairman 000 0000
Karsten Uhlmann Calciscon Board Member 000 0000
Peter Steinmann Calciscon Board Member 000 0000
Vincent Linder Ph.D Calciscon Chief Executive Officer & Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Calciscon Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Calciscon Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Be-advanced Accelerator/Incubator Minority 000 0000 000000 0
W A de Vigier Foundation Other 000 0000 000000 0
Venture Kick Accelerator/Incubator Minority 000 0000 000000 0
Robert and Ruth Heuberger Foundation Limited Partner 000 0000 000000 0
To view Calciscon’s complete investors history, request access »